Drug testing facilities should be screening for Kratom an opioid with potential for addiction and abuse. It is crucial to understand the physiological and psychological effects of Kratom, and how it is being used as an alternative to other opioids.

In this webinar, Pat Pizzo, a renowned forensic toxicologist, discusses Kratom’s legal status, and the Drug Enforcement Agency (DEA), Food and Drug Administration (FDA), and advocacy groups’ position on its safety and uses. She’ll explore the history of Kratom, where its use is trending in the US, and present data from federal organizations and research communities. Pat will conclude with compelling evidence for incorporating Kratom as part of your drug testing program.

Kratom abuse, as documented by the National Poison Data System (NPDS), is on the rise and there are lingering questions as to its true benefits and potential dangers. Understand what the Drug Enforcement Agency (DEA) and the Food and Drug Administration (FDA) know about Kratom and how that differs from advocacy groups’ perceived benefits. Learn how testing for Kratom can support better outcomes in your treatment programs.

Detailed Learning Objectives:

1. Understand how Kratom abuse is affecting the community and its potential for abuse by drug court participants

2. Understand what it is, what are its effects, and legal status

3. Learn how to test for it

Funding for this course has been provided by Thermo Fisher Scientific.

Course Type: On-Demand Presentation
Presenter: Pat Pizzo
Section: Forensic toxicology
Length: Approximately 1 hour and 30 minutes
Audience: Forensic Practitioners
Course Accreditation: Certificate of Attendance